Literature DB >> 10991881

In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.

S M Gunderson1, H Hoffman, E J Ernst, M A Pfaller, M E Klepser.   

Abstract

Four Candida albicans isolates and six non-albicans Candida isolates were evaluated by time-kill methods to characterize the relationship between nystatin concentrations, the rate and extent of fungicidal activity, and the postantifungal effect (PAFE). Against Candida species, nystatin exhibits concentration-dependent fungicidal activity and a pronounced PAFE.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10991881      PMCID： PMC90172          DOI： 10.1128/AAC.44.10.2887-2890.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic.

Authors:  M A Pfaller; R N Jones; S A Messer; M B Edmond; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1998-02       Impact factor: 2.803

2.  Evaluation of voriconazole pharmacodynamics using time-kill methodology.

Authors:  M E Klepser; D Malone; R E Lewis; E J Ernst; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

Authors:  M E Klepser; E J Wolfe; R N Jones; C H Nightingale; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods.

Authors:  E J Ernst; M E Klepser; M E Ernst; S A Messer; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1999-02       Impact factor: 2.803

5.  The in vitro post-antifungal effect of nystatin on Candida species of oral origin.

Authors:  A N Ellepola; L P Samaranayake
Journal:  J Oral Pathol Med       Date:  1999-03       Impact factor: 4.253

6.  Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.

Authors:  M E Ernst; M E Klepser; E J Wolfe; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1996 Nov-Dec       Impact factor: 2.803

Review 7.  A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis.

Authors:  M E Alvarez Alvarez; A Sánchez-Sousa; F Baquero
Journal:  Rev Esp Quimioter       Date:  1998-12       Impact factor: 1.553

8.  The postantibiotic effect of antifungal agents against common pathogenic yeasts.

Authors:  J D Turnidge; S Gudmundsson; B Vogelman; W A Craig
Journal:  J Antimicrob Chemother       Date:  1994-07       Impact factor: 5.790

9.  Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.

Authors:  E M Johnson; J O Ojwang; A Szekely; T L Wallace; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.

Authors:  E J Ernst; M E Klepser; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1998-11       Impact factor: 2.803
View more
  10 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  Shana M Gunderson; Robert A Hayes; John P Quinn; Larry H Danziger
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.

Authors:  Andreas H Groll; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Raul M Alfaro; Christine King; Stephen C Piscitelli; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

4.  Method for measuring postantifungal effect in Aspergillus species.

Authors:  Roxana G Vitale; Johan W Mouton; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp.

Authors:  Markus Nagl; Andreas Gruber; Anita Fuchs; Claudia P Lell; Eva-Maria Lemberger; Margarete Borg-Von Zepelin; Reinhard Würzner
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Safety and Tolerability of Essential Oil from Cinnamomum zeylanicum Blume Leaves with Action on Oral Candidosis and Its Effect on the Physical Properties of the Acrylic Resin.

Authors:  Julyana de Araújo Oliveira; Ingrid Carla Guedes da Silva; Leonardo Antunes Trindade; Edeltrudes Oliveira Lima; Hugo Lemes Carlo; Alessandro Leite Cavalcanti; Ricardo Dias de Castro
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-09       Impact factor: 2.629

7.  Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell.

Authors:  Špela Zemljič Jokhadar; Bojan Božič; Luka Kristanc; Gregor Gomišček
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

8.  Bursting the Virulence Traits of MDR Strain of Candida albicans Using Sodium Alginate-based Microspheres Containing Nystatin-loaded MgO/CuO Nanocomposites.

Authors:  Sadia Abid; Bushra Uzair; Muhammad Bilal Khan Niazi; Fehmida Fasim; Syeda Asma Bano; Nazia Jamil; Rida Batool; Shamaila Sajjad
Journal:  Int J Nanomedicine       Date:  2021-02-15

9.  Nystatin effect on chlorhexidine efficacy against Streptococcus mutans as planktonic cells and mixed biofilm with Candida albicans.

Authors:  Maria Eduarda Lanes Baldino; Renata Medina-Silva; Juliana Sumienski; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2021-06-23       Impact factor: 3.573

10.  Antimicrobial and toxicological studies of some metal complexes of 4-methylpiperazine-1-carbodithioate and phenanthroline mixed ligands.

Authors:  S B Kalia; G Kaushal; M Kumar; S S Cameotra; A Sharma; M L Verma; S S Kanwar
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.